Brevinin-2MP

General Information


DRACP ID  DRACP04355

Peptide Name   Brevinin-2MP

Sequence  GVITDTLKGVAKTVAAELLRKAHCKLTNSC

Sequence Length  30

UniProt ID  Not available

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C135H238N40O41S2

Absent amino acids  FMPQWY

Common amino acids  AKLT

Mass  365922

Pl  9.6

Basic residues  6

Acidic residues  2

Hydrophobic residues  12

Net charge  4

Boman Index  -2923

Hydrophobicity  21

Aliphatic Index  107.33

Half Life 
  Mammalian: 1.9 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  125

Absorbance 280nm  4.31

Polar residues  10

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34975482

Title  Antimicrobial and Anti-inflammatory Effects of a Novel Peptide From the Skin of Frog Microhyla pulchra

Doi Not available

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19003

DRACP is developed by Dr.Zheng's team.